Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How much longer till the SEC shuts this down. Drops anymore I'm going to be at 100% loss. What a shame
Has done nothing but fail consistently
Wtf is up with this ticker
Has an attorneys letter been filed yet for current status?
Going current hasn't mattered much to pps lately on several tickers
Would have been better without the cc, sheesh
It's a miracle
Integrity Health Corp
Investors Page - stock ticker $FTEG
https://www.integrityhealthcorp.com/investors
Thank You Sir
Meeting is Full
This is so fricken annoying.
Just saw on Twitter something about Fast Corp Vending https://fastcorpvending.com/divi-cbd-vending-machine-for-your-cbd-company/
Did they make the same exact error as the last letter again?
Yes previous attorney letter confirmed that this company has revenue
Its been well past 15 days and products are still selling so whats your point here?
Think of it less of a downtrend and more of a buying opportunity
It's my understanding that they will not be submitting a new attorney letter till they submit their most recent financials. That way it all gets done at the same time. I believe by May 15th was the timeframe.
Virexit Corporation making the world safe again with novel technology
Don't just clean, Virexit Clean
Things like this are going to get them in trouble https://twitter.com/OfficialPVDG/status/1389565785723613184?s=20
Where is the pump?
From what I read on Twitter, the attorney is not submitting another letter right away.
Going to be a little longer of a wait due to another amendment
Surprisingly, considering the circumstances the pps is holding up very well. Strong Hands are holding this imo.
More opportunity to buy low
What is the actual holdup with OTC reporting current status?
Someone smarter than me please answer.
Would a reverse merger from a higher price stock into a lower price stock raise the pps up of the lower price stock?
Either way there would have to be a stock split in my opinion and seeing that FTEG is becoming current while PRKI is delinquent I would have to suggest that folks at PRKI might be looking at a Stock Split merging into FTEG
PRKI is listed on OTC as Delinquent, Shell also Pink Limited with Yield sign.
January 2019 their was a PR:
FTEG's CEO, Nelson Grist said, “This Micro-biostatic Advanced Coating technology forms a protective surface protectant by forming a Nano bed of spikes that disrupts the microorganism's membrane resulting in the loss of energy in the microbe and its demise. This technology provides a perfect approach to inhibiting microorganisms without the use of unsafe heavy metals or poisons. This mode of action is entirely unique to other antimicrobials.” It is important to notice that the marketing of this product is contingent on financing.
https://www.globenewswire.com/news-release/2019/01/15/1692572/0/en/For-The-Earth-Corporation-OTC-FTEG-Preparing-to-Market-Game-Changing-Cleaning-Products.html
Says Cleaning - CBD - Skincare/Sunscreen sold through online retailers. Out of a 2000 sq ft warehouse in Arizona. Does not say how much but apparently the lawyer confirmed revenue.
Huge disappointment here
Is a RS just speculation? Any proof of this?
In other words shhh sit down the corner is over there
ONCOLOGY PHARMA DEALS
Regen BioPharma signed two deals with Oncology Pharma. One is between Oncology and Regen for treating pancreatic cancer. The second is between Regen’s wholly-owned subsidiary KCL Therapeutics, Inc and Oncology for the treatment of colon cancer.
As consideration to Regen for the rights and license granted pursuant to the Agreement Oncology Pharma shall:
(a) pay to Regen a nonrefundable fee of $55,000 no later than April 20,2021
(b) pay to Regen royalties equal to five percent (5%) of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter.
(c) pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment
As consideration to KCL Therapeutics for the rights and license granted pursuant to the Agreement Oncology Pharma shall:
(a) pay to KCL a nonrefundable fee of Fifty Thousand common shares of Oncology Pharma, Inc. no later than April 20,2021
(b) pay to KCL royalties equal to five percent (5%) of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter.
(c) pay to KCL ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which KCL receives payment
The 50,000 shares of Oncology Pharma are currently worth $1,700,000.
Sooo...what's everyone having for dinner?
10q ineffective?
In my personal opinion this has been the worst company I have ever invest in.